Jasper Therapeutics (JSPR) Q3 2025 Earnings

13AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-1.74
-1.52
-1.29
-1.07

Details

Expected EPS
-1.326311
Actual EPS
-1.74
Surprise EPS
-0.41
Surprise Percent
+31.19%

Description

Jasper Therapeutics (JSPR) has reported earnings of -1.74 per share for Q3 2025.

0 Comments

Share your thoughts